Completed PHASE4 INTERVENTIONAL 2-arm NCT02134808

Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

Placebo-Controlled Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study

Sponsor: Perry Renshaw

Conditions Major Depressive Disorder

Interventions Creatine Placebo

Updated 10 times since 2017 Last updated: Jun 10, 2024 Started: Nov 21, 2014 Primary completion: Jun 27, 2017 Completion: Jun 27, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02134808, this PHASE4 trial focuses on Major Depressive Disorder and remains completed. Sponsored by Perry Renshaw, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Aug 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2024 — Aug 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
May 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 5 earlier versions

Jun 2018 — May 2019 [monthly]

Active Not Recruiting PHASE4
Dec 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting · Phase: NA → PHASE4
Sep 2017 — Dec 2017 [monthly]

Recruiting NA
Feb 2017 — Sep 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Perry Renshaw

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States